The expression of matrix metalloproteinase-12 in the peritoneum of rats with continuous peritoneal dialysis

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Clinical and Experimental Nephrology

• Publication date

  2022-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10157-022-02297-8PMID 36371578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High glucose concentration-induced expression of pentraxin-3 in a rat model of continuous peritoneal dialysis.

  2016cited by this paper
• Macrophage Phenotype in Kidney Injury and Repair

  2015cited by this paper
• Macrophage plasticity and polarization in tissue repair and remodelling

  2013cited by this paper
• Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.

  2013cited by this paper
• A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?

  2011cited by this paper
• Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan

  2011cited by this paper
• Effect of a matrix metalloproteinase-12 inhibitor, S-1, on allergic airway disease phenotypes in mice

  2010cited by this paper
• An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing.

  2010cited by this paper
• The pathophysiology of the peritoneal membrane.

  2010cited by this paper
• Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice

  2009cited by this paper
• Peritoneal damage by peritoneal dialysis solutions

  2008cited by this paper
• Macrophage activation by endogenous danger signals

  2008cited by this paper
• Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.

  2007cited by this paper
• Improving Outcome of Capd: Twenty-Five Years’ Experience in a Single Korean Center

  2007cited by this paper
• Transforming Growth Factor (TGF)-β1 Stimulates Pulmonary Fibrosis and Inflammation via a Bax-dependent, Bid-activated Pathway That Involves Matrix Metalloproteinase-12*

  2007cited by this paper
• TGF‐β signaling and the fibrotic response

  2004cited by this paper
• Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits.

  2004cited by this paper
• High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells.

  2003cited by this paper
• Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage

  2003cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts.

  2001cited by this paper
• M-1/M-2 Macrophages and the Th1/Th2 Paradigm1

  2000cited by this paper
• Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development.

  1998cited by this paper
• Hydrolysis of a Broad Spectrum of Extracellular Matrix Proteins by Human Macrophage Elastase*

  1997cited by this paper
• Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.

  1997cited by this paper
• Effect of glucose on TGF-beta 1 expression in peritoneal mesothelial cells.

  1995cited by this paper

• Mechanisms underlying the involvement of peritoneal macrophages in the pathogenesis and novel therapeutic strategies for dialysis-induced peritoneal fibrosis

  2024cites this paper
• High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies.

  2023cites this paper